On July 29, 2026, the Hong Kong stock market showed a narrow range of fluctuations, with the Hang Seng Index fluctuating less than 200 points throughout the day, finally closing at 23,450 points, down 0.3%. The H-shares Index fell 0.2%, while the Hang Seng Tech Index bucked the trend to rise 0.5%. Although the overall market was lackluster, structural opportunities remained evident — southbound funds made net purchases for the eighth consecutive trading day, with cumulative net inflows exceeding HK$25 billion, becoming an important support force for the market.
Southbound Funds Continue to Increase Positions; High-Dividend Blue Chips Favored
As of today's close, Shanghai-Shenzhen-Hong Kong Stock Connect southbound funds had net purchases of HK$3.87 billion, of which Shanghai Connect had net purchases of HK$2.25 billion and Shenzhen Connect had net purchases of HK$1.62 billion. This marks the eighth consecutive trading day of net inflows for southbound funds. From a capital flow perspective, domestic capital is heavily allocating to high-dividend defensive stocks and tech leaders. Data shows that traditional high-dividend stocks such as China Mobile (0941.HK), CNOOC (0883.HK), and China Shenhua (1088.HK) led net purchases, with a combined net purchase of over HK$1.5 billion. Analysts pointed out that against the backdrop of heightened global uncertainty, the high-dividend strategy in Hong Kong stocks, with an average dividend yield of over 5%, is attracting steady capital inflows.
Tech Stocks Diverge; Meituan and Tencent See Strong Demand
Within the tech sector, there is clear divergence. Among the constituents of the Hang Seng Tech Index, Meituan (3690.HK) rose 2.3%, Tencent Holdings (0700.HK) rose 1.5%, while Alibaba (9988.HK) edged down 0.4%. Meituan has recently seen multiple institutions raise their target prices, mainly benefiting from better-than-expected recovery in its food delivery business and strong growth in in-store and travel services. Tencent is benefiting from expectations of normalized game license issuance, with institutions predicting several major new games in the second half of the year. Conversely, Alibaba faces greater capital outflow pressure due to lingering regulatory uncertainty.
Biopharma Sector Surges; Capital Bets on Policy Recovery
The most eye-catching sector in Hong Kong stocks today was biopharma. The Hang Seng Healthcare Index surged 2.8%, leading all industry sectors. BeiGene (6160.HK) rose 5.2%, Innovent Biologics (1801.HK) rose 4.7%, and WuXi Biologics (2269.HK) rose 3.9%. On the market news front, the National Healthcare Security Administration recently signaled support for innovative drugs, proposing to optimize pricing mechanisms and shorten the medical insurance negotiation cycle. The policy tailwind boosted early capital positioning. Additionally, many biotech companies are about to announce interim results, and the market is optimistic about core product volume expectations.
Property and Financial Sectors Under Pressure; Capital Turns Cautious
In contrast to the strength of biopharma, the property and financial sectors performed poorly today. The Hang Seng Property Sub-index fell 1.1%, with Country Garden (2007.HK) down 3.2% and Longfor Group (0960.HK) down 2.5%. This was mainly affected by rumors of debt extensions at some developers, reigniting concerns about industry liquidity. In the financial sector, HSBC Holdings (0005.HK) fell 0.8%, and Standard Chartered (2888.HK) fell 1.2%, as weakening expectations for further Fed rate hikes dragged on interest margin outlook. Analysts pointed out that although property policy continues to ease, the recovery in sales is slow, and the sector will remain under pressure in the short term.
Market Turnover Shrinks; Wait-and-See Sentiment Strong
Today's total turnover in Hong Kong stocks was HK$101.2 billion, down about 15% from the previous trading day, the lowest level in nearly a month. Market turnover has been below HK$120 billion for multiple consecutive trading days, indicating strong wait-and-see sentiment. On one hand, global markets are awaiting next week's Fed interest rate decision, and investors are taking a cautious approach. On the other hand, the mainland policy vacuum lacks clear directional guidance. However, with continued southbound fund flows through Stock Connect and the Hang Seng Index valuation at historically low levels (PE ratio around 10 times), downside is limited, and medium-term allocation value is gradually emerging.
Outlook: Structural Market May Continue
Looking ahead, institutions generally believe that Hong Kong stocks will remain volatile in the short term, but structural opportunities are worth grasping. CICC pointed out that the high-dividend strategy has good defensive properties in a rate-down cycle, recommending attention to sectors such as energy, telecom, and utilities. For growth stocks, CITIC Securities believes that stocks with strong earnings certainty in the tech and healthcare sectors are likely to achieve excess returns, especially sub-sector leaders among new Stock Connect targets. Additionally, as the August Hong Kong stock earnings season approaches, stocks with earnings surprises may see phased rallies. Investors should closely monitor southbound fund flows and policy catalysts, and flexibly adjust positions.
Overall, while the current Hong Kong stock market lacks systemic upward momentum, the optimization of capital structure and acceleration of sector rotation provide abundant trading opportunities for professional investors. Under the premise of risk control, focus can be placed on high-quality targets with sustained domestic capital buying and rising industry prosperity.
